Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2011 2
2012 1
2013 2
2014 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.
de Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group; White NH, Danis RP, Davis MD, Hainsworth D, Hubbard LD, Nathan DM. de Boer IH, et al. Arch Intern Med. 2011 Mar 14;171(5):412-20. doi: 10.1001/archinternmed.2011.16. Arch Intern Med. 2011. PMID: 21403038 Free PMC article. Clinical Trial.
BACKGROUND: Microalbuminuria is a common diagnosis in the clinical care of patients with type 1 diabetes mellitus. Long-term outcomes after the development of microalbuminuria are variable. METHODS: We quantified the incidence of and risk factors for long-term renal …
BACKGROUND: Microalbuminuria is a common diagnosis in the clinical care of patients with type 1 diabetes mellitus. Long-term o …
Comparison of digital and film grading of diabetic retinopathy severity in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
Hubbard LD, Sun W, Cleary PA, Danis RP, Hainsworth DP, Peng Q, Susman RA, Aiello LP, Davis MD; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Hubbard LD, et al. Arch Ophthalmol. 2011 Jun;129(6):718-26. doi: 10.1001/archophthalmol.2011.136. Arch Ophthalmol. 2011. PMID: 21670338 Clinical Trial.
OBJECTIVE: To compare diabetic retinopathy (DR) severity as evaluated by digital and film images in a long-term multicenter study, as the obsolescence of film forced the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervent …
OBJECTIVE: To compare diabetic retinopathy (DR) severity as evaluated by digital and film images in a long-term multicenter study, as …
Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study.
de Boer IH, Sibley SD, Kestenbaum B, Sampson JN, Young B, Cleary PA, Steffes MW, Weiss NS, Brunzell JD; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. de Boer IH, et al. J Am Soc Nephrol. 2007 Jan;18(1):235-43. doi: 10.1681/ASN.2006040394. Epub 2006 Dec 6. J Am Soc Nephrol. 2007. PMID: 17151331 Free PMC article. Clinical Trial.
Weight gain and central obesity are associated with insulin resistance, hypertension, and dyslipidemia in type 1 diabetes. These metabolic abnormalities are risk factors for kidney disease in the general population, but data addressing the relationship of central obesity w …
Weight gain and central obesity are associated with insulin resistance, hypertension, and dyslipidemia in type 1 diabetes. These meta …
Long-term effect of diabetes and its treatment on cognitive function.
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group; Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Harth J. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, et al. N Engl J Med. 2007 May 3;356(18):1842-52. doi: 10.1056/NEJMoa066397. N Engl J Med. 2007. PMID: 17476010 Free PMC article. Clinical Trial.
BACKGROUND: Long-standing concern about the effects of type 1 diabetes on cognitive ability has increased with the use of therapies designed to bring glucose levels close to the nondiabetic range and the attendant increased risk of severe hypoglycemia. METHODS: A total of …
BACKGROUND: Long-standing concern about the effects of type 1 diabetes on cognitive ability has increased with the use of therapies d …
Longitudinal changes in estimated and measured GFR in type 1 diabetes.
de Boer IH, Sun W, Cleary PA, Lachin JM, Molitch ME, Zinman B, Steffes MW; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. de Boer IH, et al. J Am Soc Nephrol. 2014 Apr;25(4):810-8. doi: 10.1681/ASN.2013050557. Epub 2013 Dec 5. J Am Soc Nephrol. 2014. PMID: 24309189 Free PMC article.
In cross-sectional and longitudinal analyses of 1441 participants in the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) study with type 1 diabetes, we compared GFR estimated …
In cross-sectional and longitudinal analyses of 1441 participants in the Diabetes Control and Complications Trial (DCCT …
Circulating vitamin D metabolites and kidney disease in type 1 diabetes.
de Boer IH, Sachs MC, Cleary PA, Hoofnagle AN, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD; Diabetes Control and Complication Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. de Boer IH, et al. J Clin Endocrinol Metab. 2012 Dec;97(12):4780-8. doi: 10.1210/jc.2012-2852. Epub 2012 Sep 18. J Clin Endocrinol Metab. 2012. PMID: 22990096 Free PMC article.
CONTEXT: Impaired vitamin D metabolism may contribute to the development and progression of diabetic kidney disease. OBJECTIVE: The aim of the study was to test associations of circulating vitamin D metabolites with risks of incident microalbuminuria, impaired glomerular f …
CONTEXT: Impaired vitamin D metabolism may contribute to the development and progression of diabetic kidney disease. OBJECTIVE: The a …
Circulating vitamin D metabolites and subclinical atherosclerosis in type 1 diabetes.
Sachs MC, Brunzell JD, Cleary PA, Hoofnagle AN, Lachin JM, Molitch ME, Steffes MW, Zinman B, de Boer IH; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Sachs MC, et al. Diabetes Care. 2013 Aug;36(8):2423-9. doi: 10.2337/dc12-2020. Epub 2013 Mar 25. Diabetes Care. 2013. PMID: 23530012 Free PMC article.
OBJECTIVE: People with type 1 diabetes are at high risk of premature atherosclerosis. Existing evidence suggests that impaired vitamin D metabolism may contribute to the development of atherosclerosis. ...CONCLUSIONS: We did not find evidence linking impaired vitamin D met …
OBJECTIVE: People with type 1 diabetes are at high risk of premature atherosclerosis. Existing evidence suggests that impaired vitami …